IsoPSA is a structure-based (rather than concentration-based) assay that interrogates the entire spectrum of structural changes to PSA (or isoforms), and can effectively differentiate between high-grade prostate cancer and low-grade prostate cancer / benign prostate disease.
Case studies are based on the use of IsoPSA as a laboratory-developed test and are provided for scientific purposes only. Any statements solely represent the opinions of the presenters or referenced authors.https://www.isopsa.com/clinical-evidence/case-studies/
GHMIGROUP is a diversified company focusing on bringing advanced healthcare solutions to emerging markets. Located in Houston, TX, USA, the company specializes in providing expert global health business solutions for global challenges such as health, research and evaluation, and health information technology.